Endoron Medical Secures $10M Series A Funding Round

Endoron Medical Secures $10M Series A Funding Round

Endoron Medical, a medtech company specializing in endograft stapling solutions for abdominal aortic aneurysms, has successfully closed a $10 million Series A funding round. The funding will be used to accelerate the clinical validation of their flagship product, the catheterbased EndoStapling solution Aortoseal, through its Investigational Device Exemption approved Early Feasibility Study (EFS).

The funding round was led by Sofinnova Partners, a renowned medtech investor, with significant contributions from the European Innovation Council Fund (EIC Fund).

Endorons innovative technology addresses challenges in sealing and securing endografts used in minimally invasive AAA repairs. The companys stapling mechanism ensures complete endograft sealing and anchoring, reducing the need for invasive surgeries. The investment will help Endoron advance its EndoStapling technology towards clinical implementation and regulatory milestones.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *